ALZN insider transaction filings
Alzamend Neuro, Inc. — 25 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-20. Screen ALZN transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-20 | 4/A | Hyperscale Data, Inc. — Director Ault Lending, LLC — Director Ault Capital Group, Inc. — Director | Grant/award (A): 7,500 (derivative) @ $1,000 | EDGAR |
| 2026-08-04 | 4 | Hyperscale Data, Inc. — Director | Grant/award (A): 7,500 (derivative) @ $1,000 | EDGAR |
| 2026-08-04 | 4 | AULT MILTON C III — Director | Grant/award (A): 7,500 (derivative) @ $1,000 | EDGAR |
| 2026-04-16 | 4 | AULT MILTON C III — Director | Purchase (P): 108,388 @ $1.00 | EDGAR |
| 2025-12-30 | 4 | AULT MILTON C III — Director | Sale (S): 1,851 @ $2.07 | EDGAR |
| 2025-12-23 | 4 | Horne William B. — Director | Sale (S): 3,333 @ $2.12 | EDGAR |
| 2025-10-24 | 4 | McGrath Lynne Fahey — Director | Sale (S): 30 @ $2.29 | EDGAR |
| 2025-10-10 | 4 | AULT MILTON C III — Director | Conversion (C): 61,743 @ $2.32 · Sale (S): 101,394 @ $2.44 · Sale (S): 20,397 @ $2.32 · Conversion (C): 143.24 (derivative) @ $1,000 | EDGAR |
| 2025-10-08 | 4 | AULT MILTON C III — Director | Conversion (C): 100,000 @ $2.32 · Sale (S): 82,033 @ $2.45 · Conversion (C): 100,000 @ $2.32 · Sale (S): 57,379 @ $2.49 · Conversion (C): 232 (derivative) @ $1,000 · Conversion (C): 232 (derivative) @ $1,000 | EDGAR |
| 2025-10-03 | 4 | AULT MILTON C III — Director | Conversion (C): 100,000 @ $2.32 · Sale (S): 36,777 @ $2.35 · Sale (S): 20,686 @ $2.39 · Sale (S): 65,903 @ $2.44 · Conversion (C): 232 (derivative) @ $1,000 | EDGAR |
| 2025-09-30 | 4 | AULT MILTON C III — Director, 10% owner | Sale (S): 37,738 @ $2.31 · Sale (S): 38,324 @ $2.31 · Sale (S): 3,566 @ $2.33 | EDGAR |
| 2025-09-25 | 4 | AULT MILTON C III — Director, 10% owner | Sale (S): 43,238 @ $2.38 · Sale (S): 39,140 @ $2.31 · Sale (S): 14,628 @ $2.31 · Conversion (C): 100,000 @ $2.32 · Conversion (C): 232 (derivative) @ $1,000 | EDGAR |
| 2025-09-23 | 4 | AULT MILTON C III — Director, 10% owner | Sale (S): 77,009 @ $2.35 · Conversion (C): 100,000 @ $2.32 · Conversion (C): 232 (derivative) @ $1,000 | EDGAR |
| 2025-09-19 | 4 | AULT MILTON C III — Director, 10% owner | Conversion (C): 100,000 @ $2.32 · Sale (S): 2,121 @ $2.45 · Sale (S): 20,870 @ $2.47 · Conversion (C): 232 (derivative) @ $1,000 | EDGAR |
| 2025-08-01 | 4 | AULT MILTON C III — Director, 10% owner | Conversion (C): 100,000 @ $2.32 · Sale (S): 29,449 @ $2.51 · Sale (S): 100,000 @ $2.22 · Conversion (C): 232 (derivative) @ $1,000 | EDGAR |
| 2025-07-29 | 4 | AULT MILTON C III — Director, 10% owner | Sale (S): 36,532 @ $2.90 · Sale (S): 8,311 @ $2.68 | EDGAR |
| 2025-07-25 | 4 | AULT MILTON C III — Director, 10% owner | Conversion (C): 143,429 @ $2.32 · Sale (S): 59,516 @ $2.95 · Sale (S): 9,621 @ $2.93 · Conversion (C): 332.76 (derivative) @ $1,000 | EDGAR |
| 2025-05-14 | 4 | AULT MILTON C III — Director, 10% owner | Sale (S): 1,213 @ $5.06 · Sale (S): 11 @ $5.28 | EDGAR |
| 2025-03-27 | 4 | Horne William B. — Director | Purchase (P): 3,334 @ $0.99 | EDGAR |
| 2025-03-25 | 4 | AULT MILTON C III — Director, 10% owner | Purchase (P): 2,905 @ $1.02 | EDGAR |
| 2025-03-24 | 4 | Katzoff David J — Chief Financial Officer | Purchase (P): 5,000 @ $1.01 | EDGAR |
| 2025-03-20 | 4 | Horne William B. — Director | Purchase (P): 5,000 @ $0.98 | EDGAR |
| 2025-03-19 | 4 | Horne William B. — Director | Option exercise (M): 10,000 @ $0.06 · Purchase (P): 5,000 @ $0.97 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | AULT MILTON C III — Director, 10% owner | Purchase (P): 5,000 @ $0.96 | EDGAR |
| 2025-03-14 | 4 | AULT MILTON C III — Director, 10% owner | Purchase (P): 100 @ $0.68 | EDGAR |
Recent 8-K events — Alzamend Neuro, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-03 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.02 — Unregistered Sales of Equity Securities 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-21 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-17 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-20 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-18 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-14 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-09 | 8-K | 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-25 | 8-K | 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-01 | 8-K | 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ALZN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →